Robuta

Sponsor of the Day: Jerkmate
https://c19early.org/bmeta.html Bromhexine for COVID-19: real-time meta-analysis of 7 studies 7 bromhexine COVID-19 controlled studies. 43% improvement, p = 0.072. covid 19 realtime meta analysis7studies https://c19early.org/rg Regdanvimab for COVID-19: real-time analysis of 17 studies Regdanvimab for COVID-19: real-time analysis of 17 studies covid 19 realtime analysis17 studies https://c19early.org/lfr Lufotrelvir for COVID-19: real-time analysis of 4 studies Lufotrelvir for COVID-19: real-time analysis of 4 studies covid 19 realtime analysis4 studies https://c19early.org/u Budesonide for COVID-19: real-time analysis of 41 studies Budesonide for COVID-19: real-time analysis of 41 studies covid 19 realtime analysisbudesonide41studies https://c19early.org/xnx Xiannuoxin for COVID-19: real-time analysis of 9 studies Xiannuoxin for COVID-19: real-time analysis of 9 studies covid 19 realtime analysisstudies https://c19early.org/mtz Metronidazole for COVID-19: real-time analysis Metronidazole for COVID-19: real-time analysis covid 19 realtime analysismetronidazole https://c19early.org/k Probiotics for COVID-19: real-time analysis of 66 studies Probiotics for COVID-19: real-time analysis of 66 studies covid 19 realtime analysisprobiotics66studies https://c19early.org/no Nitric Oxide for COVID-19: real-time analysis of 29 studies Nitric Oxide for COVID-19: real-time analysis of 29 studies covid 19 realnitric oxidetime analysis29studies https://c19early.org/b9meta.html Vitamin B9 for COVID-19: real-time meta-analysis of 18 studies (12 treatment studies and 6... 12 vitamin B9 COVID-19 controlled studies. 8% increased risk, p = 0.6. covid 19 realtime meta analysisvitamin b918studies https://c19early.org/b9 Vitamin B9 for COVID-19: real-time analysis of 46 studies Vitamin B9 for COVID-19: real-time analysis of 46 studies covid 19 realvitamin b9time analysis46studies https://c19early.org/bt Bebtelovimab for COVID-19: real-time analysis of 16 studies Bebtelovimab for COVID-19: real-time analysis of 16 studies covid 19 realtime analysis16studies https://c19early.org/chx Chlorhexidine for COVID-19: real-time analysis of 25 studies Chlorhexidine for COVID-19: real-time analysis of 25 studies covid 19 realtime analysis25 studieschlorhexidine https://c19early.org/gbp Gabapentin for COVID-19: real-time analysis of 2 studies Gabapentin for COVID-19: real-time analysis of 2 studies covid 19 realtime analysis2 studiesgabapentin https://c19early.org/pp Propolis for COVID-19: real-time analysis of 21 studies Propolis for COVID-19: real-time analysis of 21 studies covid 19 realtime analysis21 studiespropolis https://c19early.org/zan Zansecimab for COVID-19: real-time analysis Zansecimab for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/ixe Ixekizumab for COVID-19: real-time analysis Ixekizumab for COVID-19: real-time analysis covid 19 realtime analysisixekizumab https://c19early.org/hp Hydrogen Peroxide for COVID-19: real-time analysis of 27 studies Hydrogen Peroxide for COVID-19: real-time analysis of 27 studies covid 19 realhydrogen peroxidetime analysis27studies https://c19early.org/cpc Cetylpyridinium Chloride for COVID-19: real-time analysis of 24 studies Cetylpyridinium Chloride for COVID-19: real-time analysis of 24 studies covid 19 realtime analysischloride24studies https://c19early.org/cpm Chlorpheniramine for COVID-19: real-time analysis of 6 studies Chlorpheniramine for COVID-19: real-time analysis of 6 studies covid 19 realtime analysis6 studieschlorpheniramine https://c19early.org/ameta.html Favipiravir for COVID-19: real-time meta-analysis of 74 studies 74 favipiravir COVID-19 controlled studies. 11% improvement, p = 0.0096. covid 19 realtime meta analysisfavipiravir74studies https://c19early.org/ibz Ibuzatrelvir for COVID-19: real-time analysis Ibuzatrelvir for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/q Quercetin for COVID-19: real-time analysis of 120 studies Quercetin for COVID-19: real-time analysis of 120 studies covid 19 realtime analysisquercetin120studies https://c19early.org/lrmeta.html Leritrelvir for COVID-19: real-time meta-analysis of 2 studies 2 leritrelvir COVID-19 controlled studies. 21% improvement, p = 0.022. covid 19 realtime meta analysis2 studies https://c19early.org/dnase Dornase alfa for COVID-19: real-time analysis of 8 studies Dornase alfa for COVID-19: real-time analysis of 8 studies covid 19 realtime analysis8 studiesalfa https://c19early.org/s Remdesivir for COVID-19: real-time analysis of 154 studies Remdesivir for COVID-19: real-time analysis of 154 studies covid 19 realtime analysisremdesivir154studies https://c19early.org/e4 Estetrol for COVID-19: real-time analysis Estetrol for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/spv Sipavibart for COVID-19: real-time analysis of 5 studies Sipavibart for COVID-19: real-time analysis of 5 studies covid 19 realtime analysis5 studies https://c19early.org/rav Ravulizumab for COVID-19: real-time analysis of 2 studies Ravulizumab for COVID-19: real-time analysis of 2 studies covid 19 realtime analysis2 studies https://c19early.org/hh HH-120 for COVID-19: real-time analysis of 2 studies HH-120 for COVID-19: real-time analysis of 2 studies covid 19 realhh 120time analysisstudies https://c19early.org/r Casirivimab/imdevimab for COVID-19: real-time analysis of 62 studies Casirivimab/imdevimab for COVID-19: real-time analysis of 62 studies covid 19 realtime analysiscasirivimab62studies https://c19early.org/bms BMS mAbs for COVID-19: real-time analysis BMS mAbs for COVID-19: real-time analysis covid 19 realtime analysisbmsmabs https://c19early.org/sa58 SA58 for COVID-19: real-time analysis of 3 studies SA58 for COVID-19: real-time analysis of 3 studies covid 19 realtime analysis3 studiessa58 https://c19early.org/vameta.html Vitamin A for COVID-19: real-time meta-analysis of 21 studies (14 treatment studies and 7... 14 vitamin A COVID-19 controlled studies. 33% improvement, p = 0.004. covid 19 realtime meta analysis21 studiesvitamin14 https://c19early.org/paw Plasma-activated water for COVID-19: real-time analysis Plasma-activated water for COVID-19: real-time analysis covid 19 realtime analysisplasmaactivatedwater https://c19early.org/dt Diet for COVID-19: real-time analysis of 62 studies Diet for COVID-19: real-time analysis of 62 studies covid 19 realtime analysisdiet62studies https://c19early.org/efm Efmarodocokin alfa for COVID-19: real-time analysis Efmarodocokin alfa for COVID-19: real-time analysis covid 19 realtime analysisalfa https://c19early.org/o Colchicine for COVID-19: real-time analysis of 71 studies Colchicine for COVID-19: real-time analysis of 71 studies covid 19 realtime analysiscolchicine71studies https://c19early.org/atl Atilotrelvir for COVID-19: real-time analysis Atilotrelvir for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/admeta.html Adintrevimab for COVID-19: real-time meta-analysis of 2 studies 2 adintrevimab COVID-19 controlled studies. 43% improvement, p = 0.48. covid 19 realtime meta analysis2 studies https://c19early.org/x Proxalutamide for COVID-19: real-time analysis of 12 studies Proxalutamide for COVID-19: real-time analysis of 12 studies covid 19 realtime analysis12 studies https://c19early.org/pgsn rhu-pGSN for COVID-19: real-time analysis rhu-pGSN for COVID-19: real-time analysis covid 19 realtime analysisrhu https://c19early.org/egcg Epigallocatechin Gallate for COVID-19: real-time analysis of 6 studies Epigallocatechin Gallate for COVID-19: real-time analysis of 6 studies covid 19 realtime analysis6 studiesepigallocatechingallate https://c19early.org/hhmeta.html HH-120 for COVID-19: real-time meta-analysis of 2 studies 2 HH-120 COVID-19 controlled studies. 49% improvement, p = 0.25. covid 19 realtime meta analysishh 120studies https://c19early.org/evmeta.html Ensovibep for COVID-19: real-time meta-analysis of 2 studies 2 ensovibep COVID-19 controlled studies. 47% improvement, p = 0.37. covid 19 realtime meta analysis2 studies https://c19early.org/vf Vidofludimus Calcium for COVID-19: real-time analysis Vidofludimus Calcium for COVID-19: real-time analysis covid 19 realtime analysiscalcium https://c19early.org/gmeta.html Iota-carrageenan for COVID-19: real-time meta-analysis of 1 study 1 iota-carrageenan COVID-19 controlled study. 80% improvement, p = 0.018. covid 19 realtime meta analysisiotacarrageenanstudy https://c19early.org/efzo Efzofitimod for COVID-19: real-time analysis Efzofitimod for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/lvl Levilimab for COVID-19: real-time analysis Levilimab for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/ad Adintrevimab for COVID-19: real-time analysis of 3 studies Adintrevimab for COVID-19: real-time analysis of 3 studies covid 19 realtime analysis3 studies https://c19early.org/ammeta.html Amubarvimab/romlusevimab for COVID-19: real-time meta-analysis of 4 studies 4 amubarvimab COVID-19 controlled studies. 25% improvement, p = 0.51. covid 19 realtime meta analysis4 studies https://c19early.org/v Sotrovimab for COVID-19: real-time analysis of 61 studies Sotrovimab for COVID-19: real-time analysis of 61 studies covid 19 realtime analysissotrovimab61studies https://c19early.org/smeta.html Remdesivir for COVID-19: real-time meta-analysis of 81 studies 81 remdesivir COVID-19 controlled studies. 4% increased risk, p = 0.36. covid 19 realtime meta analysisremdesivir81studies https://c19early.org/dfv DFV890 for COVID-19: real-time analysis DFV890 for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/sb Sodium Bicarbonate for COVID-19: real-time analysis of 11 studies Sodium Bicarbonate for COVID-19: real-time analysis of 11 studies covid 19 realsodium bicarbonatetime analysis11studies https://c19early.org/vv Deuremidevir for COVID-19: real-time analysis of 8 studies Deuremidevir for COVID-19: real-time analysis of 8 studies covid 19 realtime analysis8 studies https://c19early.org/ic1e iC1e/K for COVID-19: real-time analysis iC1e/K for COVID-19: real-time analysis covid 19 realtime analysisk https://c19early.org/il2 Interleukin-2 for COVID-19: real-time analysis of 2 studies Interleukin-2 for COVID-19: real-time analysis of 2 studies covid 19 realtime analysisinterleukin2studies https://c19early.org/p PVP-I for COVID-19: real-time analysis of 63 studies PVP-I for COVID-19: real-time analysis of 63 studies covid 19 realtime analysispvp63studies https://c19early.org/n Nitazoxanide for COVID-19: real-time analysis of 27 studies Nitazoxanide for COVID-19: real-time analysis of 27 studies covid 19 realtime analysis27studies https://c19early.org/fm Famotidine for COVID-19: real-time analysis of 37 studies Famotidine for COVID-19: real-time analysis of 37 studies covid 19 realtime analysisfamotidine37studies https://c19early.org/ap Andrographolide for COVID-19: real-time analysis of 43 studies Andrographolide for COVID-19: real-time analysis of 43 studies covid 19 realtime analysis43studies https://c19early.org/cp Convalescent Plasma for COVID-19: real-time analysis of 95 studies Convalescent Plasma for COVID-19: real-time analysis of 95 studies covid 19 realtime analysisconvalescentplasma95 https://c19early.org/clv Clevudine for COVID-19: real-time analysis of 2 studies Clevudine for COVID-19: real-time analysis of 2 studies covid 19 realtime analysis2 studies https://c19early.org/sp Spironolactone for COVID-19: real-time analysis of 12 studies Spironolactone for COVID-19: real-time analysis of 12 studies covid 19 realtime analysis12 studiesspironolactone https://c19early.org/b12 Vitamin B12 for COVID-19: real-time analysis of 26 studies Vitamin B12 for COVID-19: real-time analysis of 26 studies covid 19 realvitamin b12time analysis26studies https://c19early.org/ppmeta.html Propolis for COVID-19: real-time meta-analysis of 3 studies 3 propolis COVID-19 controlled studies. 41% improvement, p = 0.11. covid 19 realtime meta analysis3 studiespropolis https://c19early.org/ca Cytokine Adsorption for COVID-19: real-time analysis of 2 studies Cytokine Adsorption for COVID-19: real-time analysis of 2 studies covid 19 realtime analysis2 studiescytokineadsorption https://c19early.org/ppi PPIs for COVID-19: real-time analysis of 44 studies PPIs for COVID-19: real-time analysis of 44 studies covid 19 realtime analysis44studies https://c19early.org/t Curcumin for COVID-19: real-time analysis of 110 studies Curcumin for COVID-19: real-time analysis of 110 studies covid 19 realtime analysiscurcumin110studies https://c19early.org/slx Siltuximab for COVID-19: real-time analysis of 3 studies Siltuximab for COVID-19: real-time analysis of 3 studies covid 19 realtime analysis3 studies https://c19early.org/vd Vadadustat for COVID-19: real-time analysis Vadadustat for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/amc Ammonium Chloride for COVID-19: real-time analysis of 2 studies Ammonium Chloride for COVID-19: real-time analysis of 2 studies covid 19 realtime analysis2 studiesammoniumchloride https://c19early.org/il Peginterferon Lambda for COVID-19: real-time analysis of 5 studies Peginterferon Lambda for COVID-19: real-time analysis of 5 studies covid 19 realtime analysis5 studieslambda https://c19early.org/pt Phthalocyanine for COVID-19: real-time analysis of 5 studies Phthalocyanine for COVID-19: real-time analysis of 5 studies covid 19 realtime analysis5 studies https://c19early.org/gz Glenzocimab for COVID-19: real-time analysis Glenzocimab for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/lr Leritrelvir for COVID-19: real-time analysis of 4 studies Leritrelvir for COVID-19: real-time analysis of 4 studies covid 19 realtime analysis4 studies https://c19early.org/vvmeta.html Deuremidevir for COVID-19: real-time meta-analysis of 2 studies 2 deuremidevir COVID-19 controlled studies. 11% improvement, p = 0.062. covid 19 realtime meta analysis2 studies https://c19early.org/bf Bemnifosbuvir for COVID-19: real-time analysis of 5 studies Bemnifosbuvir for COVID-19: real-time analysis of 5 studies covid 19 realtime analysis5 studies https://c19early.org/av Avdoralimab for COVID-19: real-time analysis Avdoralimab for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/nacl NaCl for COVID-19: real-time analysis of 19 studies NaCl for COVID-19: real-time analysis of 19 studies covid 19 realtime analysisnaclstudies https://c19early.org/ibmeta.html Ibuprofen for COVID-19: real-time meta-analysis of 13 studies 13 ibuprofen COVID-19 controlled studies. 0% improvement, p = 0.96. covid 19 realtime meta analysisibuprofen13studies https://c19early.org/gmmeta.html Sargramostim for COVID-19: real-time meta-analysis of 4 studies 4 sargramostim COVID-19 controlled studies. 13% increased risk, p = 0.64. covid 19 realtime meta analysis4 studies https://c19early.org/h1 Antihistamine H1RAs for COVID-19: real-time analysis of 28 studies Antihistamine H1RAs for COVID-19: real-time analysis of 28 studies covid 19 realtime analysisantihistamine28studies https://c19early.org/tm Trimodulin for COVID-19: real-time analysis Trimodulin for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/pv Pemivibart for COVID-19: real-time analysis of 12 studies Pemivibart for COVID-19: real-time analysis of 12 studies covid 19 realtime analysis12 studies https://c19early.org/ast Astegolimab for COVID-19: real-time analysis Astegolimab for COVID-19: real-time analysis covid 19 realtime analysis https://c19early.org/udcameta.html Ursodeoxycholic acid for COVID-19: real-time meta-analysis of 22 studies 22 ursodeoxycholic acid COVID-19 controlled studies. 18% improvement, p = 0.092. covid 19 realtime meta analysisacid22studies https://c19early.org/nf Nafamostat for COVID-19: real-time analysis of 17 studies Nafamostat for COVID-19: real-time analysis of 17 studies covid 19 realtime analysis17 studies https://c19early.org/naclmeta.html NaCl reduces COVID-19 risk: real-time meta-analysis of 9 studies 9 NaCl COVID-19 controlled studies. 23% improvement, p = 0.0028. reduces covid 19risk real timemeta analysisnaclstudies https://c19early.org/ppimeta.html Proton Pump Inhibitors increase COVID-19 risk: real-time meta-analysis of 40 studies covid 19 riskreal time metaprotonpumpinhibitors